Relating to a study on the prevalence of the use of psychoactive or psychotropic medication by persons who have committed suicide.

HB 967 authorizes a study to examine how commonly psychoactive or psychotropic medications are used by individuals who have died by suicide. The bill directs state health officials to analyze existing data on medication use among suicide decedents, without specifying new regulations or direct impacts on individuals. As a procedural study bill, it does not implement policy changes but would inform future public health decisions. The bill was filed in November 2024 and referred to the Public Health committee in March 2025, but the full study design and scope are not detailed in the available context.